Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase III Randomized Placebo-Controlled Trial to Determine Efficacy of Levocarnitine for Fatigue in Patients With Cancer

NCT00091169 is registered in ClinicalTrials.gov with ECOG-ACRIN Cancer Research Group as lead sponsor.

NCT NCT00091169
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00091169 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase III Randomized Placebo-Controlled Trial to Determine Efficacy of Levocarnitine for Fatigue in Patients With Cancer
Lead sponsor
ECOG-ACRIN Cancer Research Group
Phase
Phase 3
Overall status
Completed
Start date
December 16, 2005
Completion date
May 31, 2011
Enrollment
376 (actual)
Sites
116

Conditions

As the registry lists them; a condition with its own page is linked.

fatigue, unspecified adult solid tumor, protocol specific